These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 15584495

  • 1. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test.
    Ozakbas S, Ormeci B, Akdede BB, Alptekin K, Idiman E.
    Mult Scler; 2004 Dec; 10(6):686-9. PubMed ID: 15584495
    [Abstract] [Full Text] [Related]

  • 2. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M, Querol L, Escartín A.
    BMC Neurol; 2015 Mar 22; 15():40. PubMed ID: 25886168
    [Abstract] [Full Text] [Related]

  • 3. The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course?
    Coo H, Hopman WM, Edgar CM, McBride EV, Brunet DG.
    Mult Scler; 2005 Feb 22; 11(1):85-9. PubMed ID: 15732272
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
    Peyro Saint Paul L, Creveuil C, Heinzlef O, De Seze J, Vermersch P, Castelnovo G, Cabre P, Debouverie M, Brochet B, Dupuy B, Lebiez P, Sartori É, Clavelou P, Brassat D, Lebrun-Frenay C, Daplaud D, Pelletier J, Coman I, Hautecoeur P, Tourbah A, Defer G.
    J Neurol Sci; 2016 Apr 15; 363():69-76. PubMed ID: 27000224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, Zipp F, Paul F.
    Neurology; 2009 Nov 17; 73(20):1624-7. PubMed ID: 19917984
    [Abstract] [Full Text] [Related]

  • 8. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Nov 17; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 9. Paced visual serial addition test in multiple sclerosis.
    Nagels G, Geentjens L, Kos D, Vleugels L, D'hooghe MB, Van Asch P, Vuylsteke K, De Deyn PP.
    Clin Neurol Neurosurg; 2005 Apr 17; 107(3):218-22. PubMed ID: 15823678
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C, Jongen PJ, Sanders E, Sindic C, Goffette S, Dupuis M, Jacquerye P, Guillaume D, Reznik R, Wesnes K.
    BMC Neurol; 2011 Jun 07; 11():68. PubMed ID: 21649910
    [Abstract] [Full Text] [Related]

  • 13. PASAT in detecting cognitive impairment in relapsing-remitting MS.
    Rosti E, Hämäläinen P, Koivisto K, Hokkanen L.
    Appl Neuropsychol; 2007 Jun 07; 14(2):101-12. PubMed ID: 17523884
    [Abstract] [Full Text] [Related]

  • 14. The Computerized Test of Information Processing (CTIP) offers an alternative to the PASAT for assessing cognitive processing speed in individuals with multiple sclerosis.
    Tombaugh TN, Berrigan LI, Walker LA, Freedman MS.
    Cogn Behav Neurol; 2010 Sep 07; 23(3):192-8. PubMed ID: 20829669
    [Abstract] [Full Text] [Related]

  • 15. The PASAT performance among patients with multiple sclerosis: analyses of responding patterns using different scoring methods.
    Rosti E, Hämäläinen P, Koivisto K, Hokkanen L.
    Mult Scler; 2006 Oct 07; 12(5):586-93. PubMed ID: 17086904
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 07; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 20. Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator.
    Kotterba S, Orth M, Eren E, Fangerau T, Sindern E.
    Eur Neurol; 2003 Sep 07; 50(3):160-4. PubMed ID: 14530622
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.